NCT06324786

Brief Summary

The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started Sep 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Sep 2023Aug 2027

Study Start

First participant enrolled

September 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 22, 2024

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

May 4, 2026

Status Verified

May 1, 2026

Enrollment Period

4 years

First QC Date

March 6, 2024

Last Update Submit

May 1, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Intervention effects on brain function using Functional Magnetic Resonance Imaging (fMRI)

    Brain connectivity changes such as anterior and posterior cingulate cortex measured by fMRI resting state imaging

    The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

  • Intervention effects on brain white matter using fMRI

    Brain white matter changes such as anterior and posterior cingulate cortex measured by fMRI diffusion tensor imaging

    The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

  • Intervention effects on brain grey matter using fMRI

    Brain volume changes such as anterior and posterior cingulate cortex measured by fMRI structural imaging

    The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Secondary Outcomes (1)

  • Intervention effects on addiction behavior using substance use questionnaires in PhenX Toolkit

    The outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months

Study Arms (4)

IBMT

EXPERIMENTAL

An evidence-based preventive intervention - integrative body-mind training (IBMT) has shown positive effects in reducing stress and improving self-control and brain plasticity. It has bodifulness and mindfulness components.

Behavioral: IBMT

NF

EXPERIMENTAL

An evidence-based intervention - NF can not only provide real-time feedback for practice but also target the self-control networks, suggesting the possibility of augmenting IBMT effects via NF.

Behavioral: NF

IBMT + NF

EXPERIMENTAL

The combined IBMT and NF also show positive effects in reducing substance use.

Behavioral: IBMTBehavioral: NF

Sham NF

SHAM COMPARATOR

Sham NF has the same settings as the active NF but does not have correct parameters of stimulation.

Behavioral: NF

Interventions

IBMTBEHAVIORAL

IBMT is an effortless mindfulness technique

IBMTIBMT + NF
NFBEHAVIORAL

NF is a mental training technique.

IBMT + NFNFSham NF

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old
  • Free of any psychiatric diagnoses or medication (besides a substance use disorder (SUD) to alcohol, tobacco, or cannabis)
  • In the past month, at least 4 episodes of heavy episodic drinking; at least 3 occasions of cannabis use; and daily cigarette use for at least the past month
  • Normal or corrected-to-normal vision
  • Written informed consent
  • No previous meditation or NF experiences

You may not qualify if:

  • Any psychiatric diagnoses other than an SUD
  • Medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females)
  • Excluding cannabis, evidence of recent (past month) illicit drug use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

YiYuan Tang

Phoenix, Arizona, 85004, United States

RECRUITING

Central Study Contacts

YiYuan Tang

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: mindfulness or/and active/sham neurofeedback
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2024

First Posted

March 22, 2024

Study Start

September 1, 2023

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

May 4, 2026

Record last verified: 2026-05

Locations